PTEN is downregulated in the livers of NASH and HCC patients, the deletion of PTEN activates PI3K/AKT, and elevates the levels of SREBP-1c and lipogenic genes, promoting the development of NASH and HCC (88). This evidence concerns the gene PTEN and metabolic dysfunction-associated steatohepatitis.